Variation in characteristics of islets of Langerhans in insulin‐resistant, diabetic and non‐diabetic‐rat strains
Authors:
- 26 May 2010
- journal article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 91 (3) , 288-301
Abstract
Summary: Assessment of the histopathological and plasma biochemical characteristics of diabetic and non‐diabetic rat strains [Han and AP Wistar, lean and obese Zucker Fatty (ZF), and lean and obese Zucker Diabetic Fatty (ZDF) rats] was performed at 6 or 14 weeks of age. Wistar and lean ZF and ZDF rats showed no or minimal islet pathology or plasma biochemical alterations at both timepoints. Obese ZFs were euglycaemic at both timepoints and mildly and severely hyperinsulinaemic at 6 and 14 weeks respectively. Islet morphology was normal at 6 weeks but at 14 weeks, islet hyperplasia was present with a minority showing degenerative changes namely, β‐cell vacuolation, vascular congestion and haemorrhage with minimal mononuclear cell and T lymphocytic infiltration. Obese ZDFs were euglycaemic and moderately hyperinsulinaemic at 6 weeks and severely hyperglycaemic with minor hypoinsulinaemia at 14 weeks. Obese ZDFs at 6 weeks showed mainly normal islets with some displaying degeneration (ranging from β‐cell vacuolation alone to the features described above). At 14 weeks, islet degeneration was more severe and widespread: β‐cell death was present in numerous islets at low level. Islet β‐cell numbers were reduced or absent (with associated reduction in insulin immunostaining) within the islets that now consisted predominantly of fibroblasts, collagen and mononuclear cells. Fibroproliferation consisting of smooth muscle actin‐α‐positive tissue was associated with mononuclear cell infiltration. Some fibrous scars were visible indicative of lost islets. Islet degeneration in obese ZF and ZDF rats was not accompanied by a reduction in β‐cell proliferation or in compensatory proliferation of β‐cell neogenic clusters. In the light of recent reports of adaptive and inflammation‐mediated degenerative changes in human non‐insulin dependent diabetes mellitus (NIDDM) islets, the hypertrophy/hyperplasia of β‐cells and islet degeneration involving infiltration by monocyte/macrophages in obese ZF and obese ZDF rats respectively offers substantial potential for elucidation of the processes involved.Keywords
This publication has 50 references indexed in Scilit:
- Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesityCytokine, 2008
- Glucolipotoxicity: Fuel Excess and β-Cell DysfunctionEndocrine Reviews, 2008
- The MyofibroblastThe American Journal of Pathology, 2007
- Lipotoxic DiseasesAnnual Review of Medicine, 2002
- Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty ratsExperimental and Clinical Endocrinology & Diabetes, 2001
- In Zucker Diabetic Fatty Rats Plasma Leptin Levels are Correlated with Plasma Insulin Levels rather than with Body WeightHormone and Metabolic Research, 1999
- Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.Journal of Clinical Investigation, 1998
- Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK ratsEndocrinology, 1994
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus RevisitedPathology and Immunopathology Research, 1985